Alamed, J
Liraglutide, a GLP-1 Receptor Agonist, Inhibits Vascular Smooth Muscle Cell Proliferation by Enhancing AMP-Activated Protein Kinase and Cell Cycle Regulation, and Delays Atherosclerosis in ApoE Deficient Mice
Ive had countless conversations with patients who were reluctant to start GLP-1 therapy because of injection anxiety, access challenges, or affordability concerns
Diarrhea: Diarrhea is another common gastrointestinal side effect of GLP-1 medications, characterized by loose or watery stools
In the chemical stimulation assay, KCl (60 mM), carbachol (100 M
Participants in clinical trials are closely observed for potential adverse reactions, including gastrointestinal symptoms, changes in laboratory values, or unexpected systemic effects